Please enable JavaScript to view the site.

Services
What's New
Industries
What's New
Careers
What's New
Hot Topics
What's New
CN-EN Location: China-English
Contact us

CN-EN Location: China-English
Contact us

中文 |
English

Life Sciences and Health Care

The Life Sciences and Health Care industry group strives to support clients in addressing the challenges that impact today’s industry. Our network engages with clients to develop innovative solutions to help them achieve their business missions.

Get in touch with us

Industry overview
Life Sciences
Health Care
Future of Health
Publications

All
Solutions
People

Article

Deloitte China, partnered with Allergan Aesthetics and Chinese Association of Plastic and Aesthetics, launched “China Medical Aesthetic Industry Outlook 2024”

Article

Measuring the return from pharmaceutical innovation——Unleash AI’s potential

Predictions

2024 Global Life Sciences Sector Outlook

Article

China LSHC Industry Survey：2024 State of Industry in China

Analysis

2024 Global Health Care Outlook

Analysis

Insights into Chinese Medical Device Companies Going Global

Article

Recent regulatory initiatives and impact in LSHC Industry

Analysis

Sizing the brain——Segmentation and growth factors of the global neuroscience market

Article

【Deloitte HCP Omni-Channel Engagement Series】HCP 360 Playbook

Article

Deloitte Consulting, partnered with Allergan Aesthetics China, launched “China Medical Aesthetic Industry Outlook 2023”

Predictions

2023 Global Life Sciences Outlook

Predictions

2023 Global Health Care Outlook

Future of Health

Analysis

China LSHC Industry Survey Result: 2023 State of Industry in China

Article

【BIOHK2022】Thriving through change – INspire the Biotech Innovation Hub of the Future

Article

Suzhou Biomedical Industry: Updated policies (12) starting Dec. 2022

Press releases

Biopharma continues to grow from strength to strength

2023 China LSHC Investment and M&A Market Outlook

About us

CIIE Spotlight - Enhance Digital Capabilities in Life Sciences

The 5th China International Import Expo

Article

Microelectronics in Hong Kong: Innovate in a world-class research hub and accelerate through the GBA

Article

Capture business opportunities in Hong Kong's thriving I&T ecosystem

Article

Biomedical Industry: Latest support policies of Shanghai Pudong

Article

Deloitte Consulting and Allergan Aesthetics

China: Medical Aesthetic Industry Outlook 2022

Article

China Health Ecosystem 2030: A Scenarios Analysis

Article

2022 Global Life Sciences Outlook

Digitalization at scale: Delivering on the promise of science

Analysis

Challenges and Value Creation in China Life Sciences Licensing

Analysis

China LSHC Industry Survey Results: 2022 State of Industry in China

Analysis

2022 Global Health Care Outlook

Are we finally seeing the long-promised transformation?

Analysis

Future of Trust Survey Results in China LSHC Industry

Article

Yearbook of patient assistance in China 2021

Article

2021 China LSHC M&A Market Whitepaper

Article

Deloitte Partner Jens Ewert receives 2021 Shanghai Magnolia Silver Award

Article

Outlook on biopharma innovation trends in China

Article

2021 Global Life Sciences Outlook: Possibility is
now reality, sustaining forward momentum

Article

China's Biotech Parks – Leveraging the ecosystem for success

Article

Safeguarding biopharma R&D – New heights in China's human genetic resources management

Article

Internet Hospitals in China: The new step into digital healthcare

Predictions

2021 Global Health Care Outlook: Accelerating industry change

Article

Chinese Medical Device Industry: How to thrive in an increasingly competitive market?

Analysis

2021 China LSHC Industry Survey Results: ‘State of Industry’

Article

Biotech-in-a-box™: A three-step game plan for biotech

How to ‘ACE’ geographical expansion in Europe

Article

China Aesthetic Medicine Market Outlook Report

Article

Deloitte explored digitalization in pharma industry with EUCCC

Article

Deloitte China LSHC Tax Seminar Recap and Industry Survey

Press releases

Deloitte launches Future of Heath 1.0 for China at CIIE with exclusive insights from globally renowned respiratory expert Dr. Zhong Nanshan

Research suggests eight trends will re-define the future of health in China

Article

Trends in Talent Incentives at Social Medical Service Institutions

Article

Deloitte facilitates talent cultivation and management for social medical organizations

Deloitte satellite forum at China Social Medical Summit 2020 concluded successfully

Article

Winning in the Future of Health

Deloitte-Morgan Stanley Online Satellite Forum at WuXi Healthcare Forum Concluded Successfully

Article

How pharma companies can address the retail market transformations in China

Article

China as a digital transformation sandbox: A prescription for pharma multinationals

Article

New Medical Reform in China: Pharma Companies' Tax Challenges, Opportunities and Responses

Deloitte China LSHC Leader interview with ICS

View on pharmaceutical investment in Shanghai

Deloitte China LSHC Leader interview with ICS

Let’s make this work.

To view this video, change your analytics/performance cookie settings.

Article

Winning in the cell and gene therapies market in China

Article

Deloitte & Alibaba Cloud explored the Digital Innovation in China Healthcare Sector

Article

2020 China Life Sciences and Health Care M&A Trends

Article

Deloitte spoke at AmCham Shanghai Healthcare Committee webinar

Perspectives

Tax update on China's pharma & healthcare sector after COVID-19

Press releases

Six predictions for China's pharma & healthcare sector

Analysis

Snapshot survey of COVID-19 impact on China pharma industry

Article

Winning in the future of medtech

Novel partnerships with consumer tech to transform care delivery

Topic page promos custom CSS. Do not delete! This box/component contains JavaScript that is needed on this page. This message will not be visible when page is activated.

Contact us

Contact us via our online form.

Events

Register for our events and seminars.

Newsroom

Read our latest news and information.

Solutions

Life Sciences and Health Care Industry

In China, Deloitte has an elite team of over 700 bilingual professionals to effectively communicate with clients, thoroughly understand their business needs and provide comprehensive solutions that meet their goals.
Life Sciences

Deloitte China Life Sciences Industry practice works closely with our global counterparts to provide industry players in pharmaceuticals, biotechnology, medical devices, pharmaceutical distribution and CRO with full and feasible solutions with new thinking.
Health Care

Our Health Care team provides audit, tax, financial advisory services, consulting services and enterprise risk services for health care providers, including hospitals, professional service providers, outpatient facilities and long term care.
Deloitte Global Life Sciences and Health Care Industry

Global reach that you can count on.

Get In Touch

Jens Ewert

China LSHC Industry Leader

jensewert@deloitte.com.cn

Contact Deloitte
Submit RFP
Search Jobs

Global office directory Office locations

CN-EN Location: China-English

About Deloitte

Home
Social Media
Newsroom
Events
Deloitte Foundation
Alumni
Deloitte INED Club
China Office Directory
Press releases
Submit RFP
Contact us

Services

Industries

Careers

Hot Topics

About Deloitte
About Deloitte China
Terms of use
Cookies
Privacy

© 2024. See Terms of Use for more information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), and its network of member firms, and their related entities. DTTL and each member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. Please see About Deloitte to learn more about our global network of member firms.